Construction began in that year, and production was put into operation in that year. It only took 4 and a half months to complete the Weigao Litong Biomedicine Phase II mRNA vaccine project, which is the "Weihai speed". At present, it has entered the trial production stage of the novel coronavirus mRNA vaccine, which is the first mRNA vaccine technology platform in Shandong. It is also the first technology platform project in China with both traditional vaccine preparation and nucleic acid vaccine preparation, and the first medical platform project in China with independent technical property rights to break through international technical barriers in nucleic acid vaccine technology for novel coronavirus.
At the same time, this project is also one of the many benchmark biological vaccine engineering projects that Jason gypsum Board has helped to participate in. The interior installation project of the vaccine research and development center, pilot workshop and production workshop of this technology platform project uses the special deep processing gypsum board customized by Jason for its comprehensive consumption of more than 100,000 square meters.
In 2022, the domestic epidemic can be described as one after another. From the battle of Changchun to the battle of Greater Shanghai, from the 80,000 stranded in Sanya to the unexpected outbreak in Lhasa, COVID-19 has spread on the Qinghai-Tibet Plateau, the roof of the world...... In view of the complex and changing situation of the novel coronavirus epidemic, Weigao Group urgently started the construction of the phase II mRNA vaccine project. As a key project in Shandong Province and a major project to be started in Weihai City in 2022, Weigao Litong biological vaccine project has been running on the "highway" since it was not yet under construction.
If the normal construction schedule is followed, the project will take at least one and a half years to complete. However, in the face of the severe epidemic situation, time waits for no one. In order to effectively ensure the project construction progress and supply on time and smoothly, Jason gypsum board professional and technical personnel, after repeated discussions, urgently adjusted the production implementation plan, and took out the production scheduling plan and scheduling plan at the first time, providing a strong guarantee for the project's special gypsum board supply and smooth construction.
It is understood that the overall land area of Weigolitong Phase II mRNA vaccine project is 200 mu, the plant area is planned to be 2.78 million square meters, and the total investment is 10 billion yuan, to carry out research and industrialization in multi-valent new coronavirus vaccine, AIDS vaccine, and new rabies vaccine. It is expected that after the full completion of the project, the annual output of various vaccines will reach 80 million, with an output value of 8 billion yuan. At present, Weigolitong Phase II mRNA vaccine project has entered the trial production stage of COVID-19 mRNA vaccine. According to the relevant person in charge, the new coronavirus mRNA vaccine is expected to submit clinical applications in October, and strive to obtain clinical trial approval by the end of the year to carry out clinical trials.
Up to now, in order to fight against the COVID-19 epidemic and help the construction of COVID-19 vaccine medical engineering projects, Jason Gypsum Board has provided customized gypsum board products and services for the vaccine and pharmaceutical production workshops of many large biomedical groups, including Beijing Sinovac COVID-19 vaccine production workshop, China Biological Vaccine production workshop, Sinopsin Purification workshop, Qilu Pharmaceutical Group and so on. The comprehensive dosage is more than one million cubic meters. In the future, Jason Plasterboard will continue to work with the Biomedical Group to fully assist the construction of mRNA vaccine industrialization bases around the country, and jointly contribute to the development of China's biomedical industry and the cause of anti-epidemic!
